Sichenzia Ross Ference LLP Represents A.G.P. in $2.2 Million Common Stock Offering
Press Release – New York, NY – January 31, 2020 – Sichenzia Ross Ference LLP announced today that it represented A.G.P./Alliance Global Partners as sole placement agent in a $2.2 million offering of common stock at $0.63 per share of Cocrystal Pharma, Inc. (NASDAQ: COCP), a clinical stage biotechnology company developing antiviral therapeutics. The shares were offered and sold pursuant to Cocrystal’s effective registration statement on Form S-3 (Registration No. 333-220632).
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia and Avital Perlman and associate Grant Levine.
- Sichenzia Ross Ference LLP Obtains Dismissal of $2.6 Million Contract Claims On Appeal - October 15, 2020
- Sichenzia Ross Ference LLP Represents H.C. Wainwright in $7.5 Million At-The-Market Offering of Ekso Bionics - October 15, 2020
- Sichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in $15 Million Initial Public Offering of Amesite Inc. - September 30, 2020